Adamas Pharmaceuticals Liabilities 2024

Adamas Pharmaceuticals Aktienanalyse

What does Adamas Pharmaceuticals do?

Adamas Pharmaceuticals, Inc. is an American biopharmaceutical company specializing in the development of therapies for neurological diseases. It was founded in 2000 by Gregory Went and Mark Gergen and is headquartered in Emeryville, California. The company's goal is to develop groundbreaking therapies that can improve the lives of people with neurological diseases, particularly focusing on the treatment of Parkinson's disease, multiple sclerosis, and epilepsy. Adamas Pharmaceuticals' business model is based on the discovery, development, and commercialization of novel drugs based on patient needs and scientific insights. The company collaborates closely with leading scientists, doctors, and patient organizations to maximize the effectiveness of its medications. Adamas Pharmaceuticals is divided into several business units, each specializing in different neurological diseases, including Parkinson's disease, multiple sclerosis, and epilepsy. The company has developed GOCOVRI, the first and only medication for the treatment of dyskinesias in Parkinson's disease patients. It is also working on medications for multiple sclerosis and epilepsy. Adamas Pharmaceuticals has partnerships with other pharmaceutical companies, including a collaboration with Biogen, a leading biotechnology company specializing in neurological disease therapies. The company is dedicated to making significant advancements in the fight against neurological diseases through its focus on patient needs and collaboration with scientists and doctors. Adamas Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Adamas Pharmaceuticals's Liabilities

Adamas Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Adamas Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Adamas Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Adamas Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Adamas Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Adamas Pharmaceuticals stock

What is the level of liabilities of Adamas Pharmaceuticals this year?

Adamas Pharmaceuticals has a debt balance of 0 USD this year.

What were the liabilities of Adamas Pharmaceuticals compared to the previous year?

The liabilities of Adamas Pharmaceuticals have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Adamas Pharmaceuticals?

High liabilities can pose a risk for investors of Adamas Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Adamas Pharmaceuticals?

Low liabilities mean that Adamas Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Adamas Pharmaceuticals affect the company?

An increase in liabilities of Adamas Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Adamas Pharmaceuticals affect the company?

A decrease in the liabilities of Adamas Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Adamas Pharmaceuticals?

Some factors that can influence the liabilities of Adamas Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Adamas Pharmaceuticals so important for investors?

The liabilities of Adamas Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Adamas Pharmaceuticals take to modify the liabilities?

To change its liabilities, Adamas Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Adamas Pharmaceuticals pay?

Over the past 12 months, Adamas Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Adamas Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Adamas Pharmaceuticals?

The current dividend yield of Adamas Pharmaceuticals is .

When does Adamas Pharmaceuticals pay dividends?

Adamas Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Adamas Pharmaceuticals?

Adamas Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Adamas Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Adamas Pharmaceuticals located?

Adamas Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Adamas Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Adamas Pharmaceuticals from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Adamas Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Adamas Pharmaceuticals in the year 2023?

In the year 2023, Adamas Pharmaceuticals distributed 0 USD as dividends.

In which currency does Adamas Pharmaceuticals pay out the dividend?

The dividends of Adamas Pharmaceuticals are distributed in USD.